SCOPE Summit 2026
February 2-5 | Orlando, FL
Our team would love to meet with you to demonstrate how MMIT, Panalgo, and our NorstellaLinQ data asset deliver end-to-end support from clinical trial planning to market access intelligence, powered by real-world evidence, AI-enabled analytics, and expert-level support.
Meet with us to discuss:
- Bridging the gap between clinical development and market access.
- Leveraging early evidence generation and real-world outcomes to demonstrate value, safety, and efficacy in the development process.
- Using integrated real-world data to support clinical trial diversity, optimizing trial design, identifying complex or rare patient populations, and discovering innovative clinical strategies.
- Improving data integration, speeding time to insights, and better aligning market access decisions.
Whether you’re a clinical trial specialist or a market access leader, we’d love to meet to see how we can help your team find success from development to launch.
Meet with Us
NorstellaLinQ
NorstellaLinQ is the first and only fully integrated data asset combining real-world data and Norstella’s proprietary intelligence from the most trusted brands in the industry.
Ella AI
Our GenAI assistant made for asking questions in plain language and getting answers fast—no filters, no coding, just clarity.
Trigger Alerts
Powered by NorstellaLinQ, Trigger Alerts surface high-value patients and their treating physicians within days of a clinical event—so you can act while it still matters.
LinQNotes
LinQNotes is an exploratory tool that allows users to search and interact with unstructured clinical data, giving your teams instant context into how patient care is navigated to uncover directional insights that inform strategy.